NCT07412769

Brief Summary

Standardization According to GINA 2025 Recommendations for the Treatment, Management, and Follow-up of Acute Asthma Attacks: Observational, Multicenter Cohort Study.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2025

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 5, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 26, 2026

Completed
22 days until next milestone

First Posted

Study publicly available on registry

February 17, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Completed
Last Updated

February 17, 2026

Status Verified

February 1, 2026

Enrollment Period

7 months

First QC Date

January 26, 2026

Last Update Submit

February 13, 2026

Conditions

Keywords

asthma attack, exacerbation,

Outcome Measures

Primary Outcomes (5)

  • Change in the number of correctly reported diagnoses before and after intervention

    Assessment of adherence to guideline-based diagnostic and therapeutic management of pediatric patients presenting with acute asthma exacerbations in the emergency department.

    Pre-intervention and through study completion, an average of 9 months

  • Percentage of patients with correct timing, dosage, and method of drug administration before and after intervention

    Pre-intervention and through study completion, an average of 9 months

  • Percentage of patients with correct follow-up at discharge

    Pre-intervention and through study completion, an average of 9 months

  • Percentage of patients in whom additional drugs are used in refractory cases

    Pre-intervention and through study completion, an average of 9 months

  • Percentage of patients with correct therapy at discharge

    Pre-intervention and through study completion, an average of 9 months

Secondary Outcomes (1)

  • Incidence of acute asthma exacerbations

    Pre-intervention and through study completion, an average of 9 months

Study Arms (2)

Pre-intervention cohort

Pediatric patients aged 6-17 years presenting to the emergency department with an acute asthma exacerbation during the pre-intervention period (October 2024-May 2025). Patients received standard care according to local clinical practice prior to the implementation of the structured educational intervention. Intervention: No intervention (standard of care)

Post-intervention cohort

Pediatric patients aged 6-17 years presenting to the emergency department with an acute asthma exacerbation during the post-intervention period (October 2025-May 2026), after the implementation of a structured educational intervention for emergency department staff. Intervention: Educational intervention (health care provider-directed)

Eligibility Criteria

Age6 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of pediatric patients aged 6 to 17 years presenting to the emergency departments of two Italian tertiary-care hospitals (AOU IRCCS Meyer Children's Hospital in Florence and Arcispedale S. Anna in Ferrara) with an acute asthma exacerbation. Eligible patients were identified through retrospective review of electronic medical records of all emergency department visits occurring during the predefined study periods. Patients were included if they received a discharge diagnosis consistent with acute asthma exacerbation or related conditions (e.g., bronchospasm, asthma attack, asthmatic bronchitis, wheezing).

You may qualify if:

  • Age between 6 and 17 years
  • Presentation to the emergency department with a diagnosis of acute asthma exacerbation
  • Evaluation in the emergency department of one of the participating centers during the study periods

You may not qualify if:

  • Age \< 6 years or \> 17 years
  • Diagnosis other than acute asthma exacerbation
  • Incomplete or missing clinical data
  • Patients transferred from other hospitals already treated for the same episode
  • history of allergy to any drugs used in the protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Arcispedale S. Anna

Ferrara, FE, 44124, Italy

RECRUITING

Meyer Children's Hospital IRCCS, Firenze

Florence, 50134, Italy

RECRUITING

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 26, 2026

First Posted

February 17, 2026

Study Start

November 5, 2025

Primary Completion

May 31, 2026

Study Completion

June 30, 2026

Last Updated

February 17, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations